Atara Biotherapeutics, Inc. (LON: 0HIY)

Atara Biotherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	32	41	258	1,029	1,191	673
Market Cap Growth	-71.93%	-84.11%	-74.90%	-13.57%	76.82%	-45.88%
Enterprise Value	18	9	102	783	961	472
Last Close Price	5.60	11.43	66.91	309.26	476.45	755.05
PS Ratio	0.46	6.10	4.90	68.51	-	-
PB Ratio	-0.51	-0.53	2.46	4.98	3.52	3.07
P/TBV Ratio	-	-	2.46	4.98	3.52	3.07
EV/Sales Ratio	0.22	1.36	1.93	52.15	-	-
Debt / Equity Ratio	-0.55	-0.61	0.57	0.10	0.03	0.05
Asset Turnover	0.61	0.03	0.15	0.04	-	-
Inventory Turnover	17.54	40.39	-	-	-	-
Quick Ratio	0.44	0.61	3.60	3.52	6.06	7.05
Current Ratio	0.59	0.72	3.74	3.64	6.31	7.43
Return on Equity (ROE)	-	-2014.86%	-112.39%	-91.69%	-81.43%	-92.43%
Return on Assets (ROA)	-45.03%	-62.11%	-40.64%	-40.29%	-41.49%	-50.30%
Return on Capital (ROIC)	-	-210.90%	-67.79%	-54.20%	-49.28%	-57.22%
Earnings Yield	-308.33%	-528.31%	-73.36%	-24.41%	-18.86%	-32.63%
FCF Yield	-219.63%	-371.56%	-88.25%	-16.58%	-11.40%	-27.06%
Buyback Yield / Dilution	-40.71%	-3.85%	-8.88%	-26.63%	-44.17%	-17.11%
Total Shareholder Return	-40.71%	-3.85%	-8.88%	-26.63%	-44.17%	-17.11%

Source: S&P Capital IQ. Standard template. Financial Sources.